Remove Development Remove Life Science Remove Pharma R&D
article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and speed up time to market whilst improving outcomes, and most recognise that incorporating automation and AI into their workflows will be game-changing. ” Changing team culture. Ensuring a future of Computer-Aided Biology.

article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

“When you stand back and look at that overall context, what seems to have happened is that pharma and investors have suddenly gone, ‘You know what, maybe you can do these quicker and faster without breaking things’,” says managing director of life sciences and healthcare for Silicon Valley Bank UK, Nooman Haque. “If